Immunogenicity of New Primary Immunization Schedules With Inactivated Poliovirus Vaccine and Bivalent Oral Polio Vaccine for the Polio Endgame: A Review.
Bandyopadhyay, Ananda S; Modlin, John F; Wenger, Jay; Gast, Chris.
Clin Infect Dis
; 67(suppl_1): S35-S41, 2018 Oct 30.
Artigo em Inglês | MEDLINE | ID: mdl-30376081
Update on Vaccine-Derived Polioviruses - Worldwide, January 2014-March 2015.
Update on vaccine-derived polioviruses - worldwide, July 2012-December 2013.
Planning for globally coordinated cessation of bivalent oral poliovirus vaccine: risks of non-synchronous cessation and unauthorized oral poliovirus vaccine use.
[Comparing the immunogenicity and safety of sequential inoculation of sIPV followed by bOPV (â +â ¢) in different dosage forms].
Preventing Vaccine-Derived Poliovirus Emergence during the Polio Endgame.
The differential impact of oral poliovirus vaccine formulation choices on serotype-specific population immunity to poliovirus transmission.
Fractional-Dose Inactivated Poliovirus Vaccine Campaign - Sindh Province, Pakistan, 2016.
Update on Vaccine-Derived Polioviruses - Worldwide, January 2017-June 2018.
Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of potential non-synchronous cessation.
Immune Serum From Sabin Inactivated Poliovirus Vaccine Immunization Neutralizes Multiple Individual Wild and Vaccine-Derived Polioviruses.